Table 1.

Patient and transplant characteristics

Characteristic	Value
Total patients, n	99
Sex, n
Female	48
Male	51
Median age in years at transplant (range)	55 (20-74)
Diagnosis, n
Acute lymphoblastic leukemia	13
Acute myeloid leukemia	61
Myelodysplastic syndrome	25
Disease Risk Index, n
Low	3
Intermediate	61
High	32
Very High	3
Donor type, n
Matched related donor	39
Matched unrelated donor	51
Mismatched related donor	3
Mismatched unrelated donor	6
Graft source, n
Bone marrow	1
Peripheral blood stem cells	98
Conditioning intensity, n
Myeloablative	44
Reduced intensity/non-myeloablative	55
GVHD prophylaxis backbone, n
Cyclosporine/methotrexate	8
Cyclosporine/mycophenolate mofetil	2
Tacrolimus/methotrexate	63
Tacrolimus/sirolimus	9
Tacrolimus/sirolimus/methotrexate	17
ATG for GVHD prophylaxis, n
Yes	25
No	74
CMV reactivation
Total, n	27
Before day +100, n	18
Before day +30, n	4

Abbreviations: ATG: anti-thymocyte globulin; GVHD: graft-versus-host disease;